Stocks
CONMED (CNMD) EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 113.6 | 158.4 | 7.80 | 209.1 | 182.2 | 228.7 | ||
| Changes by years, y/y, % | -9% | +39% | -95% | +2 581% | -13% | +20.6% | |||
CONMED. EBITDA US GAAP, bln rub
CONMED. EBITDA US GAAP, changes, %
CONMED. EBITDA US GAAP, sum by quarters, bln rub
CONMED (CNMD) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | 61.0 | 61.0 | 54.9 | 47.1 | 65.7 | 228.7 | |
| Changes by years, y/y, % | -5 668% | -5 668% | +333% | +72% | +117% | |||
| Changes by quarters, q/q, % | +101% | 0% | -10% | -14% | +39% | |||
